Frontline treatment approaches in TP53-aberrant mantle cell lymphoma

Authors:

Abstract
Mantle cell lymphoma (MCL) is an incurable B-cell lymphoma with no current standard of care. Treatment options range from surveillance to intensive chemoimmunotherapy followed by autologous stem ce...
Funding Information
  • Biostatistics & Bioinformatics Shared Resource at the H. Lee Moffitt Cancer Center & Research Institute
  • National Cancer Institute and funded in part by Moffitt’s Cancer Center (P30-CA076292)

This publication has 15 references indexed in Scilit: